Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alcon signs five-year contract with LCA-Vision
Under the contract, LCA will place Allegretto Wave Eye-Q 400Hz excimer lasers in all of the company’s 75 LasikPlus vision surgery centers by the end of the third
Under the contract, LCA will place Allegretto Wave Eye-Q 400Hz excimer lasers in all of the company’s 75 LasikPlus vision surgery centers by the end of the third
The European Commission decision, based on a favorable opinion from the European Medicines Agency, follows the designation of KNS-760704 as an orphan drug for the treatment of amyotrophic
The results of Phase I studies are expected to be available in April 2009. Based on these and other results, Avineuro Pharmaceuticals plans to advance AVN-211 into Phase
Under the terms of the agreement, the Israeli Ministry of Health will fund all costs associated with development of the antiserum and the establishment of a GMP manufacturing
Mr Phillippe will assume the position of CFO from Alexander Krantz, who has served as CFO since October 23, 2006. Mr Krantz will continue to act as president,
His responsibilities included supervision of a pilot plant facility, a drug delivery device laboratory, and a core cell culture facility. Prior to Geron, he was associate director, process
Ferring Pharmaceuticals, USA has announced the commercial availability of degarelix for injection, a new injectable gonadotropin-releasing hormone receptor antagonist approved by the FDA for the treatment of hormone
Solta Medical, a provider of anti-aging solutions, has opened the Solta Medical Aesthetic Center to advance the company’s new product development, facilitate research on the Thermage and Fraxel
For the fourth quarter ended December 31, 2008, revenue from continuing operations was $21.9 million, against $12.4 million for the same period in 2007, and $19.0 million for
2008 Highlights Record revenues of $7.1 million in the last quarter Cash and cash equivalents totalling $2.4 million Restructured its debentures and received new financing facilities from Desjardins